Personalized mRNA technology, which gained global fame during the COVID-19 pandemic, is now showing remarkable potential in the fight against some of the deadliest cancers. Recent clinical updates from leading pharmaceutical companies and research institutions highlight sustained benefits for patients with pancreatic…